In This Article:
Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including Unity Software's (U) upgrade to Buy from Jefferies analysts, UiPath (PATH) beating its earnings estimates, and Regeneron Pharmaceuticals (REGN) taking a stock hit on its mixed drug trial results for an experimental treatment to a condition referred to as smoker's lung.
Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.
It's time for Yahoo! Finance's market minute. Stocks lower today, but poised to close the month of May in positive territory. Tensions between the US and China heating up, as President Trump claims the country violated its side of the trade agreement. Unity software getting an upgrade to buy from hold at Jeffries. The analyst citing an improved vector ad model that he expects to drive revenue growth through full year 2026 and beyond. And shares of software company, UiPath, higher after topping earnings expectations and lifting its guidance. The results easing fears the dosage cuts would affect earnings. And shares of pharmaceutical company Regeneron sinking after reporting mixed results for its experimental drug for a condition called Smoker's lung. While trial one saw positive results here, the drug failed in a separate late stage trial. An HSBC analyst saying the mixed results will make the regulatory path for the drug murky. And that's your Yahoo! Finance market minute. For more on what's trending on Yahoo! Finance, scan the QR code below.
